Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by ...

When Robert Stone thinks about what makes City of Hope stand apart, it's the people. He recalls a patient who stopped him, a ...

The fate of an important breakthrough in cancer immunotherapy treatment remains in the balance following an announcement ...

ANSWER: Gynecomastia is the growth of male breast tissue, specifically when not due to breast cancer. It can happen during ...

The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Patient dosing has continued to successfully escalate in an early-phase trial of a novel FSHR-targeting CAR T-cell therapy in ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

The biotechnology company said late Monday that Health Canada issued a Notice of Compliance with Conditions for its treatment, Amtagvi, for adult patients with unresectable or metastatic melanoma that ...

Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...

Women with a 20% or greater risk of breast cancer now have a new resource at Lexington Medical Center’s high-risk clinic, ...